Dow Up0.11% Nasdaq Up0.50%

T. Rowe Price Health Sciences (PRHSX)

69.05 Up 0.45(0.66%) Aug 29

Profile as of Jul 30, 2014Get Profile for:
T. Rowe Price Health Sciences
100 East Pratt StreetBaltimore MD 21202
Phone: 800-638-5660
Fund Overview 
Fund Family:T. Rowe Price
Net Assets:9.46B
Year-to-Date Return:11.61%
Morningstar Rating:5 stars
Fund Inception Date:Dec 29, 1995
Morningstar Style Box 
[View Category Definition]
View Top Health Funds
About the Morningstar Style Box
Management Information 
Taymour R. Tamaddon
Lead Manager since Feb 15, 2013
Investment Information 
Min Initial Investment:2,500
Min Initial Investment, IRA:1,000
Min Initial Investment, AIP:2,500
Min Subsequent Investment:100
Min Subsequent Investment, IRA:100
Min Subsequent Investment, AIP:100
PRHSX can be purchased from 115 brokerages.

Fund Summary 
The investment seeks long-term capital appreciation. The fund normally invests at least 80% of its net assets (including any borrowings for investment purposes) in the common stocks of companies engaged in the research, development, production, or distribution of products or services related to health care, medicine, or the life sciences (collectively termed "health sciences"). While it can invest in companies of any size, the majority of fund assets are expected to be invested in large- and mid-capitalization companies. The fund may invest in foreign stocks and options in keeping with the fund's objectives.

Fund Operations 
Last Dividend : 0.00
Last Cap Gain (Dec 15, 2013) : 0.00
Annual Holdings Turnover (Aug 27, 2014) : 45.70%
Average for Category:50.71%
Fees & Expenses 
ExpensePRHSXCategory Avg
Annual Report Expense Ratio (net):0.79%1.39%
Prospectus Net Expense Ratio:0.79%N/A
Prospectus Gross Expense Ratio:0.79%N/A
Max 12b1 Fee:0.00%N/A
Max Front End Sales Load:N/A5.28%
Max Deferred Sales Load: N/A2.37%
3 Yr Expense Projection*:252664
5 Yr Expense Projection*:4391,040
10 Yr Expense Projection*:9782,040
* Per $10,000 invested